MUNICH, Germany, June 17, 2026 – HMNC Brain Health (“HMNC” or the “Company”), a clinical-stage neuroscience company, today announced the appointment of Dr. Bjørn Grønning as Chief Medical Officer (CMO), effective immediately, following the planned transition of Dr. Hans Eriksson.